AirTree Ventures

AirTree Ventures is one of the leading early-stage venture firms in Australia and New Zealand, operating from Sydney with a thesis focused on backing founders building ambitious software and technology companies from the region. The firm has built its reputation on early conviction, hands-on partnership, and a portfolio that includes some of the most successful ANZ technology companies of the past decade.

Within healthcare AirTree concentrates on AI and machine learning applications, digital health, and tech-enabled care delivery, with particular interest in companies integrating ambient AI into clinical documentation and remote patient monitoring. Ambience Healthcare is a recognizable example of the kind of investment the firm makes, where AI applied to clinical workflows has potential to scale across hospital and physician practice customers globally. The thesis emphasizes founders with technical credibility and a clear understanding of healthcare buyer dynamics, which is necessary for software companies operating in clinical environments.

Check sizes typically run from one to five million dollars at entry, with the firm participating from pre-seed through Series B. Follow-on capacity scales with conviction, allowing AirTree to maintain meaningful ownership through growth rounds in companies that perform. Geographic focus is Australia and New Zealand with selective activity in companies that maintain ANZ founders or substantial regional operations even when expanding internationally. The firm’s relationships with downstream international investors give portfolio companies access to global growth capital as they scale, which is critical in a regional ecosystem where the largest checks generally need to come from outside.

The team is structured around sector-focused partners and supported by a portfolio operations group that includes talent, growth, and platform functions. AirTree has invested deliberately in platform value-add as a competitive differentiator, treating early-stage venture as a service business as much as a capital allocation business, and that orientation shows up in how the firm engages with its companies day-to-day.

For founders, AirTree is one of the natural early-stage venture choices in Australia and New Zealand, particularly for ambitious software and AI companies including those in healthcare. The firm’s introductions are most valuable for international expansion, downstream fundraising with global investors, and senior hiring through the platform talent network. Post-investment engagement is hands-on at the early stages and active through later rounds, with partners taking board seats and engaging consistently on strategy, hiring, and fundraising. Founders looking for an investor that will engage substantively rather than nominally will find the cultural fit strong, while those who prefer maximum autonomy may find the firm’s expectations demanding. For AI in healthcare, digital health, and tech-enabled care delivery companies built from ANZ with global ambitions, AirTree is among the firms that consistently appears on the shortlist for founders who have done the work of identifying the most credible regional partners.